ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Modeling: Like The Sims But No Graphics

November 26, 2010

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000